Cargando…
1975. 1 g vs. 2 g Daily Intravenous Ceftriaxone in the Therapy of Community-onset Pneumonia: A Propensity Score Analysis From a Data of Japanese Multicenter Registry
BACKGROUND: Community-acquired pneumonia (CAP) is one of the most common infectious diseases and is an important cause of mortality and morbidity worldwide. The prognosis of CAP in adults is associated with factors such as age, comorbidities, vital signs, laboratory data, and other factors on admiss...
Autores principales: | Hasegawa, Shinya, Sada, Ryuichi, Yaegashi, Makito, Mori, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254774/ http://dx.doi.org/10.1093/ofid/ofy210.1631 |
Ejemplares similares
-
1g versus 2 g daily intravenous ceftriaxone in the treatment of community onset pneumonia – a propensity score analysis of data from a Japanese multicenter registry
por: Hasegawa, Shinya, et al.
Publicado: (2019) -
Retrospective Comparison of the Effectiveness and Safety of Ceftriaxone 1 g Twice Daily versus 2 g Once Daily for Treatment of Aspiration Pneumonia
por: Kato, Hideo, et al.
Publicado: (2022) -
Cholestatic hepatitis with intravenous ceftriaxone
por: Kaur, Inderpal, et al.
Publicado: (2011) -
Cutaneous drug reaction with intravenous ceftriaxone
por: Kaur, Inderpal, et al.
Publicado: (2009) -
Clinical Outcomes of Ceftriaxone vs Penicillin G for Complicated Viridans Group Streptococci Bacteremia
por: Wo, Stephanie, et al.
Publicado: (2020)